85 related articles for article (PubMed ID: 1399946)
21. Comparative in-vitro activity of RP 59500 against clinical bacterial isolates.
Inoue M; Okamoto R; Okubo T; Inoue K; Mitsuhashi S
J Antimicrob Chemother; 1992 Jul; 30 Suppl A():45-51. PubMed ID: 1399950
[TBL] [Abstract][Full Text] [Related]
22. Post-antibiotic effect of the new streptogramin RP 59500.
Chin NX; Neu HC
Eur J Clin Microbiol Infect Dis; 1992 Jul; 11(7):642-5. PubMed ID: 1396777
[TBL] [Abstract][Full Text] [Related]
23. The in-vitro activity of new streptogramins, RP 59500, RP 57669 and RP 54476, alone and in combination.
Neu HC; Chin NX; Gu JW
J Antimicrob Chemother; 1992 Jul; 30 Suppl A():83-94. PubMed ID: 1328138
[TBL] [Abstract][Full Text] [Related]
24. In vitro activity of RP 74501-RP 74502, a novel streptogramin antimicrobial mixture, against clinical isolates of Legionella species.
Edelstein PH; Edelstein MA
Antimicrob Agents Chemother; 1993 Apr; 37(4):908-10. PubMed ID: 8494390
[TBL] [Abstract][Full Text] [Related]
25. Killing kinetics of RP 59500 and pristinamycin against penicillin-resistant pneumococci.
Barakett V; Lesage D; Delisle F; Richard G; Petit JC
Pathol Biol (Paris); 1997 May; 45(5):438-40. PubMed ID: 9296100
[TBL] [Abstract][Full Text] [Related]
26. RP 59500, a streptogramin derivative, is effective in murine listeriosis.
Nichterlein T; Kretschmar M; Hof H
J Chemother; 1996 Apr; 8(2):107-12. PubMed ID: 8708741
[TBL] [Abstract][Full Text] [Related]
27. Characterization of erythromycin-resistant Streptococcus pneumoniae in Korea, and In Vitro activity of telithromycin against erythromycin-resistant Streptococcus pneumoniae.
Kim NJ; Park SJ; Choi SH; Lee MS; Choo EJ; Kwak YG; Woo JH; Ryu J; Jeong JY; Kim YS
Microb Drug Resist; 2005; 11(3):260-5. PubMed ID: 16201929
[TBL] [Abstract][Full Text] [Related]
28. In vitro bactericidal activities of ABT-773 against ermB strains of Streptococcus pneumoniae.
Neuhauser MM; Prause JL; Danziger LH; Pendland SL
Antimicrob Agents Chemother; 2003 Mar; 47(3):1132-4. PubMed ID: 12604554
[TBL] [Abstract][Full Text] [Related]
29. E test as an alternative to conventional MIC determination for surveillance of drug resistant Streptococcus pneumoniae.
Lalitha MK; Manayani DJ; Priya L; Jesudason MV; Thomas K; Steinhoff MC
Indian J Med Res; 1997 Dec; 106():500-3. PubMed ID: 9439095
[TBL] [Abstract][Full Text] [Related]
30. RP 59500 prophylaxis of experimental endocarditis due to erythromycin-susceptible and -resistant isogenic pairs of viridans group streptococci.
L'Hériteau F; Entenza JM; Lacassin F; Leport C; Glauser MP; Moreillon P
Antimicrob Agents Chemother; 1995 Jul; 39(7):1425-9. PubMed ID: 7492079
[TBL] [Abstract][Full Text] [Related]
31. Comparative in-vitro activity of RP 59500.
Verbist L; Verhaegen J
J Antimicrob Chemother; 1992 Jul; 30 Suppl A():39-44. PubMed ID: 1399949
[TBL] [Abstract][Full Text] [Related]
32. In vitro antibacterial activity of beta-lactams and non-beta-lactams against Streptococcus pneumoniae isolates from Sydney, Australia.
Gosbell IB; Fernandes LA; Fernandes CJ
Pathology; 2006 Aug; 38(4):343-8. PubMed ID: 16916725
[TBL] [Abstract][Full Text] [Related]
33. Antimicrobial susceptibility of invasive Streptococcus pneumoniae in Italy by agar dilution method and E test.
Tarasi A; Venditti M; D'Ambrosio F; Pantosti A
Microb Drug Resist; 1999; 5(3):215-8. PubMed ID: 10566872
[TBL] [Abstract][Full Text] [Related]
34. Bactericidal activity of moxifloxacin compared to grepafloxacin and clarithromycin against Streptococcus pneumoniae and Streptococcus pyogenes investigated using an in vitro pharmacodynamic model.
Esposito S; Noviello S; Ianniello F
J Chemother; 2000 Dec; 12(6):475-81. PubMed ID: 11154028
[TBL] [Abstract][Full Text] [Related]
35. In vitro antistaphylococcal activity and testing of RP 59500, a new streptogramin, by two methods.
Aldridge KE; Schiro DD; Varner LM
Antimicrob Agents Chemother; 1992 Apr; 36(4):854-5. PubMed ID: 1503448
[TBL] [Abstract][Full Text] [Related]
36. Anhydrolide macrolides. 1. Synthesis and antibacterial activity of 2,3-anhydro-6-O-methyl 11,12-carbamate erythromycin A analogues.
Elliott RL; Pireh D; Griesgraber G; Nilius AM; Ewing PJ; Bui MH; Raney PM; Flamm RK; Kim K; Henry RF; Chu DT; Plattner JJ; Or YS
J Med Chem; 1998 May; 41(10):1651-9. PubMed ID: 9572890
[TBL] [Abstract][Full Text] [Related]
37. Activity of moxifloxacin and twelve other antimicrobial agents against 216 clinical isolates of Streptococcus pneumoniae.
Esposito S; Noviello S; Ianniello F
Chemotherapy; 2001; 47(2):90-6. PubMed ID: 11173809
[TBL] [Abstract][Full Text] [Related]
38. In vitro activity of the ketolide ABT-773.
Barry AL; Fuchs PC; Brown SD
Antimicrob Agents Chemother; 2001 Oct; 45(10):2922-4. PubMed ID: 11557491
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and antibacterial activity of novel 4''-O-carbamoyl erythromycin-A derivatives.
Qi Y; Jiao B; Ma X; Cui W; Ma S
Arch Pharm (Weinheim); 2010 Aug; 343(8):458-64. PubMed ID: 20803622
[TBL] [Abstract][Full Text] [Related]
40. Induction of ribosome methylation in MLS-resistant Streptococcus pneumoniae by macrolides and ketolides.
Zhong P; Cao Z; Hammond R; Chen Y; Beyer J; Shortridge VD; Phan LY; Pratt S; Capobianco J; Reich KA; Flamm RK; Or YS; Katz L
Microb Drug Resist; 1999; 5(3):183-8. PubMed ID: 10566867
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
